IL2 and neoplasm: Despite FPC2‐IG‐IL‐2 induced enrichment of tumor‐infiltrating cytotoxic lymphocytes, FPC2‐IG‐IL‐2 injection alone did not induce a sufficient antitumor immune response against CT26 tumors.